Clinical features of pediatric Graves' orbitopathy

被引：16

作者：

Eha J. ^{[1
]}

Pitz S. ^{[1
]}

Pohlenz J. ^{[2
]}

机构：

[1] Department of Ophthalmology, Johannes Gutenberg-University, 55101 Mainz

[2] Pediatric Endocrinology, Children's Hospital, Johannes Gutenberg-University, Mainz

来源：

International Ophthalmology | 2010年 / 30卷 / 6期

关键词：

Children; Graves' disease; Graves' orbitopathy; Orbitopathy; Pediatric;

D O I：

10.1007/s10792-010-9351-6

中图分类号：

学科分类号：

摘要：

Pediatric Graves' orbitopathy is rare, thus its clinical picture is less well defined in comparison with the adult population. Therefore it is our aim to describe the clinical spectrum at our tertiary referral center. We identified 11 patients under the age of 18 years (3♂, 8♀; range 3-16 years, mean age 14.5 years) with Graves' disease and signs of orbitopathy. Seven of them where reevaluated (mean follow-up 25 months, range 3-66 months). Eyelid retraction and proptosis were the predominant signs in 10/11 of our patients. In six patients, Hertel readings ranged from 22 mm or above. Mild ocular motility impairment was seen in four children. Active orbitopathy or severe impairment of visual acuity/ocular motility, corneal or optic nerve involvement was not observed in our study. Our series confirms that pediatric Graves' orbitopathy lacks significant inflammatory features; however, proptosis is common and may be marked. All seven patients who were reevaluated did not show any clinically significant change of ocular signs during the observation period. In particular, there was no improvement of proptosis despite restoration of euthyroidism. © Springer Science+Business Media B.V. 2010.

引用

页码：717 / 721

页数：4

共 21 条

[1]

Acuna O.M., Athannassaki I., Paysse E.A., Association between thyroid-stimulating immunoglobulin levels and ocular findings in pediatric patients with Graves disease, Transactions of the American Ophthalmological Society, 105, pp. 146-150, (2007)

[2]

Chan W., Wong G.W.K., Fan D.S.P., Cheng A.C.K., Lam D.S.C., Ng J.S.K., Ophthalmopathy in childhood Graves' disease, British Journal of Ophthalmology, 86, 7, pp. 740-742, (2002)

[3]

Krassas G.E., Segni M., Wiersinga W.M., Childhood Graves' ophthalmopathy: Results of a European questionnaire study, Eur J Endocrinol, 153, pp. 515-521, (2005)

[4]

Krassas G.E., Treatment of juvenile Graves' disease and its ophthalmic complication: The 'European way, European Journal of Endocrinology, 150, 4, pp. 407-414, (2004)

[5]

Bergman P., Auldist A.W., Cameron F., Review of the outcome of management of Graves' disease in children and adolescents, Journal of Paediatrics and Child Health, 37, 2, pp. 176-182, (2001)

[6]

Prummel M.F., Bakker A., Wiersinga W.M., Baldeschi L., Mourits M.P., Kendall-Taylor P., Perros P., Neoh C., Dickinson A.J., Lazarus J.H., Lane C.M., Heufelder A.E., Kahaly G.J., Pitz S., Orgiazii J., Hullo A., Pinchera A., Marcocci C., Sartini M.S., Rocchi R., Nardi M., Krassas G.E., Halkias A., Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: The first European Group on Graves' Orbitopathy experience, European Journal of Endocrinology, 14

[7]

Uretsky S.H., Kennerdell J.S., Gutai J.P., Graves' ophthalmopathy in childhood and adolescence, Archives of Ophthalmology, 98, 11, pp. 1963-1964, (1980)

[8]

Wong G.W.K., Cheng P.S., Increasing incidence of childhood Graves' disease in Hong Kong: A follow-up study, Clinical Endocrinology, 54, 4, pp. 547-550, (2001)

[9]

Durairaj V.D., Bartley G.B., Garrity J.A., Clinical features and treatment of graves ophthalmopathy in pediatric patients, Ophthalmic Plastic and Reconstructive Surgery, 22, 1, pp. 7-12, (2006)

[10]

Shibayama K., Ohyama Y., Yokota Y., Ohtsu S., Takubo N., Matsuura N., Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' Disease, Endocrine Journal, 52, 5, pp. 505-510, (2005)

← 1 2 3 →